Results 11 to 20 of about 419 (109)

Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis [PDF]

Frontiers in Cardiovascular Medicine, 2022
An extremely dystrophic, premature female infant, born at 25 3/7 weeks of gestational age (birth weight: 430 g) with severe pulmonary hypertension (PH), was admitted to our neonatal intensive care unit (ICU) requiring cardiorespiratory support, including
Hosan Hasan, Hosan Hasan, Klea Hysko, Klea Hysko, Thomas Jack, Thomas Jack, Jens Dingemann, Martin Wetzke, Georg Hansmann, Georg Hansmann   +9 more
doaj   +2 more sources

The Clinical Approach to Interstitial Lung Disease in Childhood: A Narrative Review Article [PDF]

Children
Interstitial lung disease (ILD) comprises a group of respiratory diseases affecting the interstitium of the lungs, which occur when a lung injury triggers an abnormal healing response, and an inflammatory process leads to altered diffusion and ...
Simona Drobňaková, Veronika Vargová, László Barkai   +2 more
doaj   +2 more sources

Pulmonary interstitial glycogenosis: an unrecognized etiology of persistent pulmonary hypertension of the newborn in congenital heart disease? [PDF]

Pediatr Cardiol, 2013
Pulmonary interstitial glycogenosis (PIG) arises from a developmental disorder of the pulmonary mesenchyme and presents clinically with reversible neonatal respiratory distress and/or persistent pulmonary hypertension of the newborn (PPHN).We report two cases of PIG in patients with congenital heart disease (CHD) and evidence of PPHN.Both cases ...
Radman MR, Goldhoff P, Jones KD, Azakie A, Datar S, Adatia I, Oishi PE, Fineman JR.   +7 more
europepmc   +8 more sources

Lipofibroblast Phenotype in Pulmonary Interstitial Glycogenosis. [PDF]

Am J Respir Crit Care Med, 2016
Deutsch GH, Young LR.
europepmc   +4 more sources

Pulmonary interstitial glycogenosis: an independent disease or morphological manifestation of the spectrum of interstitial lung diseases in infants?

Zdorovʹe Rebenka, 2018
The article presents a modern view on the problem of pulmonary interstitial glycogenosis, describes a typical clinical and morphological picture of the disease, and considers the disease etiology and the possibility of pulmonary interstitial glycogenosis
O.L. Logvinova, M.A. Gonchar
doaj   +2 more sources

Interstitial lung disease in infancy and early childhood: Clinical approach. [PDF]

Pediatr Pulmonol
Pediatric Pulmonology, Volume 60, Issue S1, Page S24-S26, March 2025.
Bush A.
europepmc   +2 more sources

Thoracotomies in Children in Low to Middle Income Countries: The Indications for Surgery. [PDF]

Pediatr Pulmonol
ABSTRACT Introduction There is a scarcity of data on the utilization of thoracotomy for lung pathology in children in low‐ and middle‐income countries (LMICs). These countries have high burdens of infectious diseases, especially tuberculosis, hydatic disease and Human immunodeficiency virus (HIV).
Botha J, Goussard P, Janson J, Ismail Z, Kim J, Retief F, Burke J, Gie A, Rhode D, Schubert P, Andronikou S.   +10 more
europepmc   +2 more sources

Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease. [PDF]

Pediatr Pulmonol
ABSTRACT The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non‐cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer.
Cheng PC, Liptzin DR, Garagozlo K, Barber AT.   +3 more
europepmc   +2 more sources

Genetic Testing Utilization in the U.S. Registry for Childhood Interstitial and Diffuse Lung Diseases. [PDF]

Pediatr Pulmonol
ABSTRACT Introduction Childhood interstitial and diffuse lung diseases (chILD) comprise a diverse group of rare disorders. Identifying the underlying cause is crucial for treatment, prognosis, and estimating recurrence risk. The objective of this study was to assess the utilization of genetic testing for subjects enrolled in the United States National ...
Voss LA, Nevel RJ, Wambach JA, Nogee LM, Deterding RR, Casey AM, O'Connor MG, Craven DI, Taylor JB, Deutsch GH, Tam-Williams JB, Steffes LC, Brennan SK, Santiago MT, Sadreameli SC, Heras AF, Powers MR, Popova AP, Bansal M, Hamvas A, Gower WA, Urrego F, Young LR, ChILD Registry Collaborative.   +23 more
europepmc   +2 more sources

"We Could Hold Our Own Here at Home": Longitudinal Experience of COVID-19 Lockdowns in Parents With Children Affected With Interstitial Lung Disease. [PDF]

Pediatr Pulmonol
ABSTRACT The global health emergency of COVID‐19 in early 2020 placed much of the population under quarantine. Interstitial Lung Disease in childhood (chILD) was recommended to be a pediatric clinically extremely vulnerable (CEV) group in April 2020 for shielding due to the unknown health consequences of COVID‐19 in children with chronic respiratory ...
Gilbert C, Bush A, Bennett KM, Brown C.
europepmc   +2 more sources